Tag: on-small cell lung cancer

Phase III Study of Genentech’s Alecensa® (alectinib) Showed Superior Efficacy Versus Crizotinib in Japanese People with a Specific Type of Lung Cancer

by Editor • May 18, 2016

South San Francisco, CA May 18, 2016 Genentech Press Release First investigational head-to-head study of Alecensa versus crizotinib in people with advanced ALK-positive non-small cell lung cancer (NSCLC) SOUTH SAN FRANCISCO, CA — 2016-05-18 00:00:00 Genentech, a member of…

FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer

by Editor • April 11, 2016

South San Francisco, CA April 11, 2016 Press Release -Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA)…